The dilution of shares in Vicore Pharma is increasing as the company approaches important research results. #VicorePharma #Bioteknik #Börs (translated)

The dilution of shares in Vicore Pharma is increasing as the company approaches important research results. #VicorePharma #Bioteknik #Börs (translated)

The research company Vicore Pharma reports an operating loss of -133 million Swedish kronor for the third quarter of 2026, which is an increase from -116 million Swedish kronor the previous year. #VicorePharma #finans #börs (translated)
